Intravenous C band Ultraviolet Light Therapy (IVUVLT) as a treatment for bacterial and viral infections including Covid 19

Sagar Jawale

Volume : IX, Issue : V, May - 2020

Intravenous C band Ultraviolet Light Therapy (IVUVLT) as a treatment for bacterial and viral infections including Covid 19

Sagar Jawale

Abstract :

Introduction: Antibiotic resistance developed by micro–organisms is getting scary day by day and WHO estimates that drug–resistant diseases could cause 10 million deaths each year by 2050 and loss of up to 100 trillion USD to the whole world. To solve this problem, I started my own research to find a solution to this upcoming disaster. I have invented a new therapy called Intravenous Ultraviolet Light Therapy (IVUVLT) which is likely to be effective in variety of bacterial and viral infections including covid19. Materials and Methods: Intravenous Ultraviolet Light Therapy (IVUVLT) illuminates ultraviolet light of 254 nm wavelength into a peripheral vein with a fiber optical device. The device is made up of a 3–watt ultraviolet light bulb of quartz material. A PMMA (Poly methyl methacrylate) fiber carries UV light of 254 nm wavelength and delivers it through an angiocath to the patient�s blood in a peripheral vein. Discussion: The UV light of 254 nm wavelength kills all bacteria, viruses, fungi and molds in 60 seconds. PMMA material is non–reactive to blood and already FDA approved for use inside human body. The device for IVUVLT is commercialized for a reasonable cost of Rs. 15,000. The probe of the device is reusable, detachable and sterilized by ETO gas or by putting in Formalin chamber for 30 minutes. IVUVLT and its device are reported for the first time in medical literature. UV light of 254 nm wavelength is a non– ionizing radiation and proved to be safe in many studies done on human body. The blood cells are exposed to UV light only for few seconds and the progenitors in bone marrow are not exposed keeping them safe. Ultraviolet Blood Irradiation (UBI) is a procedure that exposes the blood to UV light to heighten the body�s immune response and to kill infections. It is similar to IVUVLT in many ways and has shown positive effects on RBCS, neutrophils, lymphocytes, on phagocytosis and on redox status. The light of 254 NM splits the 2% dissolved Oxygen in the blood and converts it into molecular Ozone O3. Ozone is a non–toxic gas and kills all micro–organisms like bacteria, fungi, viruses and molds in just 60 seconds. It is effective in little concentration as 0.04 ppm and human toxicity starts at 3 ppm indicating a huge safety limit. Ozone is a strong modulator of immune system. Inside the blood, it creates a mild oxidative stress which makes the immune system produce a large quantity of Interferons, agents that attack micro–organisms and kills them. No resistance is reported to Ozone and UV light making them a never–failing solution to micro– organisms. There are numerous studies in the medical literature which show that the UV light kills bacteria and viruses in the animal studies as well as studies done on human body. IVUVLT is going to be effective against vast number of viral infections such as HIV– AIDS, COVID 19, Swine flu, Dengue fever, Japanese encephalitis, Rabies, viral diarrheas, rabies etc. which kill millions of people yearly worldwide. It will also be effective against bacterial septicemia, tetanus, meningitis, Diphtheria and against Methicillin–resistant Staphylococcus aureus (MRSA) etc. It will also be effective against systemic fungal infections and molds. The therapy will work against unknown organisms leading to pyrexia of unknown origin (PUO). I do not claim to know everything about IVUVLT. A lot of research and numerous clinical trials will be necessary to know about its exact mechanism of action, dosages and indications. This is only the beginning of this kind of research. Conclusions: IVUVLT is a potentially safe, cheap and effective therapy for septicemia secondary to vast majority of viral and bacterial infections including Covid19. We need more research and a greater number of patients to know more about it. The therapy has a potential to save many patients worldwide from variety of infections. The therapy can be used as an immediate measure in epidemics and pandemics for new infections with unknown micro–organisms even before a specific vaccine and treatment is developed